CoChat

Study protocol: Apps and peer support for a healthy future and living well with diabetes (APHLID-M)

Open access
Mathews, K.O., MacMillan, F., Wong, V., Craig, M., Greenfield, J.R., Hicks, R., Jones, T., Poynten, A., Wong, T., Reyes, M., Tannous, K., Wilson, C., Hay, P., Abdo, S., Piya, M.K., Lai, J., Venigalla, M., Thomson, R., Simmons, D. · 2025 · Contemporary Clinical Trials Communications

The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index; none of the 36 sources its claims cite is checked for support yet.

Abstract

Background: Mental health conditions are common among non-pregnant young people with any form of diabetes, affecting diabetes self-management and increasing complications risk. Limited evidence exists on whether smartphone applications "apps" combining diabetes and mental health (MH) support can improve self-management and MH in these young people. The Apps and Peer support for a Healthy future and Living Well with Diabetes (APHLID-M) multicentre study includes two randomised controlled trials (RCTs) testing such an app, aimed at reducing distress among young adults with diabetes with and without a mental health condition (MHC). Methods and analysis: An app containing diabetes and MH resources was configured onto a pre-existing, digital health platform. Young adults aged 16-30 years with diabetes will be recruited from eight Australian outpatient clinics, screened using the Kessler Psychological Distress Scale (K10) and the Problem Areas in Diabetes (PAID) questionnaires. Based on MH status, participants will be allocated to the primary RCT (MHC group) or a nested-exploratory RCT (No-MHC group) and randomised by site to the "app" (Intervention) or "no app" (control). All participants will have access to peer support and will continue to receive standard diabetes care through their clinic. Recruitment will end once 142 participants are enrolled in the primary RCT. The primary outcome is change in psychological distress (K10), and the secondary outcome change in HbA1c, assessed at baseline and 6 months. Discussion: APHLID-M will offer valuable insights into effects of digital technology in enhancing MH (particularly distress) physical health and well-being in young people with diabetes.

Overview

CoChat Summary

TL;DR

APHLID-M is a multicentre study protocol with two randomised controlled trials testing a configured Perx Health app plus peer support versus usual care in young adults aged 16–30 years with diabetes, with a primary RCT for those with a mental health condition and a nested exploratory RCT for those without. It aims to assess change in psychological distress (K10) and HbA1c at 6 months.

Key findings

  • No trial outcome results are reported; this is a protocol. The primary RCT will enrol 142 participants (64 per group plus 14 to allow for 10% attrition) to detect a moderate K10 effect size of 0.5 with power 0.8 and alpha 0.05.
  • Participants are screened with K10 and PAID; K10 ≥20 or PAID ≥40, or self-reported diagnosed mental health history/current mental health care, classifies them as having a mental health condition (MHC). Those with K10 ≥40 and PAID ≥20 are considered for referral but not excluded.
  • Primary outcome is change in psychological distress (K10) at baseline and 6 months; secondary outcomes include HbA1c, diabetes-related distress (PAID), weight, and hospital/emergency department admissions.
  • The app was configured onto the Perx Health platform with separate T1DM and T2DM Health Hubs; all participants receive peer support and a physical activity tracker, while intervention participants get app resources ad libitum plus in-app communications approximately every 4–5 days.

Methods

  • Two multi-site RCTs across eight Australian outpatient clinics; eligible participants are aged 16–30 years with T1DM, T2DM, or rare forms of diabetes, own a smartphone, can provide written informed consent, are not pregnant, and speak English. Recruitment was planned July 2023–April 2024, with data collection to October 2024.
  • Randomisation to “app” or “no app” within each study is by minimisation stratified within site; allocation is not concealed from participants or healthcare workers, but research staff collecting data and the statistician are blinded. The MHC group forms the primary RCT and the No-MHC group the nested exploratory RCT.
  • Analysis uses linear mixed effects regression for K10 with participant ID and site as random effects and age, gender, ethnicity, socio-economic status, diabetes type, time, and intervention group as fixed effects; the group×time interaction is tested at α = 0.05. Secondary outcomes use linear mixed models with Benjamini-Hochberg false discovery rate control, count outcomes use Poisson generalised linear mixed models, and intention-to-treat with multiple imputation is planned if needed; qualitative interviews use the RE-AIM framework and reflexive thematic analysis.

Limitations

  • Stated: the primary RCT sample size (n = 142) allows for 10% loss to follow-up, but greater loss could impact detecting a moderate K10 effect size of 0.5; the short follow-up limits insights into sustainability; the nested No-MHC arm was not independently powered; and no formal pilot study specific to youth with diabetes has been conducted, though the platform has been used in young people with cystic fibrosis.
  • Evident from the text: allocation is not concealed from participants or healthcare workers, and the app is only available in English, excluding non-English speakers.
  • Evident from the text: this is a protocol, so no effectiveness, safety, or cost-effectiveness results are yet available.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1016/j.conctc.2025.101484

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig. 1 Apps and Peer support for a Healthy future and Living well with Diabetes (APHLID-M) study design.
Fig. 1 Apps and Peer support for a Healthy future and Living well with Diabetes (APHLID-M) study design.CC BY · PubMed Central

Verification

Claims the paper makes

0 Valid · 0 Not valid · 28 Not checked · 44 Own results and interpretations

18 more claims

Create a free account to see all 72 claims and to verify the 32 references still open.

See all claims — free account
  • Probably not a substantial claim. 43
  • It may state two separate claims as one. 22

Create a free account to see these claims.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

3 of 3

Citations

Cites

Show all 41 references

Cited by

See all 1

Metadata

Authors
Mathews, K. O., MacMillan, F., Wong, V., Craig, M., Greenfield, J. R., Hicks, R., Jones, T., Poynten, A., Wong, T., Reyes, M., Tannous, K., Wilson, C., Hay, P., Abdo, S., Piya, M. K., Lai, J., Venigalla, M., Thomson, R., & Simmons, D.
Affiliations
  • Western Sydney University (AU)
  • Liverpool Hospital (AU)
  • Children's Hospital at Westmead (AU)
  • UNSW Sydney (AU)
  • Goulburn Valley Health (AU)
  • Prince of Wales Hospital (AU)
  • St George Hospital (AU)
  • Camden and Campbelltown Hospitals (AU)
Corresponding author
Simmons, D.
Venue
Contemporary Clinical Trials Communications
Publisher
Elsevier BV
Published
2025-06
Volume
45
Pages
101484
ISSN
2451-8654 (ISSN-L)
OpenAlex
W4409424194
Cited by
1
References
41
Citations by year
2026: 1
FWCI
0.45
Type
journal article
Language
en
Open access
Licence
Locations
  • Contemporary Clinical Trials Communications (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Sydney Partnership for Health, Education, Research and Enterprise
  • Health Education and Training Institute
  • Butterfly Foundation
  • Department of Industry, Science and Resources
  • Abbott Laboratories
  • Australian Government Department of Health and Aged Care
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
  • Health Sciences › Health Professions › General Health Professions › Mobile Health and mHealth Applications
  • Social Sciences › Psychology › Applied Psychology › Digital Mental Health Interventions
Keywords
diabetes mellitus, mental health, psychological distress, mobile application, digital health, peer support, young adults, diabetes self-management, HbA1c, diabetes complications, Kessler Psychological Distress Scale, Problem Areas in Diabetes

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-11-20, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-11-20 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Study protocol: Apps and peer support for a healthy future and living well with diabetes (APHLID-M). https://app.cochat.ai/papers/10.1016/j.conctc.2025.101484
The paper
Mathews, K. O., MacMillan, F., Wong, V., Craig, M., Greenfield, J. R., Hicks, R., Jones, T., Poynten, A., Wong, T., Reyes, M., Tannous, K., Wilson, C., Hay, P., Abdo, S., Piya, M. K., Lai, J., Venigalla, M., Thomson, R., & Simmons, D. (2025). Study protocol: Apps and peer support for a healthy future and living well with diabetes (APHLID-M). Contemporary Clinical Trials Communications. https://doi.org/10.1016/j.conctc.2025.101484

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.